LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
+4.92%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.79B
AUM Growth
+$2.79B
(-27%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-50.79%
Top 10 Holdings %
Top 10 Hldgs %
47.1%
Holding
407
New
129
Increased
35
Reduced
53
Closed
119
Top Buys
| 1 |
General Motors
GM
|
$158M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$121M |
| 3 |
Honeywell
HON
|
$75.5M |
| 4 |
BP
BP
|
$59.7M |
| 5 |
Walt Disney
DIS
|
$45.8M |
Top Sells
| 1 |
Apple
AAPL
|
$437M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$400M |
| 3 |
T-Mobile US
TMUS
|
$180M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$168M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$118M |
Sector Composition
| 1 | Healthcare | 37.2% |
| 2 | Consumer Staples | 12.28% |
| 3 | Consumer Discretionary | 9.01% |
| 4 | Utilities | 7.23% |
| 5 | Industrials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Medtronic
MDT
$118B
| $10.3M | 0.09% |
+125,317
| New | +$10.3M |
|
52
Mineralys Therapeutics
MLYS
$1.94B
| $9.94M | 0.08% |
1,156,068
+186,090
| +19% | +$1.6M |
|
53
CME Group
CME
$97.1B
| $9.48M | 0.08% |
45,004
-28,754
| -39% | -$6.06M |
|
54
Deere & Co
DE
$127B
| $9.4M | 0.08% |
+23,498
| New | +$9.4M |
|
55
Recursion Pharmaceuticals
RXRX
$2.02B
| $8.95M | 0.08% |
907,616
| – | – |
|
56
Gilead Sciences
GILD
$140B
| $8.76M | 0.07% |
+108,096
| New | +$8.76M |
|
57
Coca-Cola
KO
$297B
| $8.73M | 0.07% |
148,108
-155,329
| -51% | -$9.15M |
|
|
LSXMA
58
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $8.61M | 0.07% |
299,533
-102,047
| -25% | -$2.93M |
|
59
Scholar Rock
SRRK
$3.3B
| $8.5M | 0.07% |
452,146
-101,554
| -18% | -$1.91M |
|
60
Applied Optoelectronics
AAOI
$1.44B
| $7.99M | 0.07% |
+413,611
| New | +$7.99M |
|
61
Delta Air Lines
DAL
$40B
| $7.75M | 0.07% |
192,726
-165,047
| -46% | -$6.64M |
|
62
Elevance Health
ELV
$72.4B
| $7.54M | 0.06% |
+15,985
| New | +$7.54M |
|
63
Acumen Pharmaceuticals
ABOS
$82.4M
| $7.28M | 0.06% |
1,895,023
| – | – |
|
64
Vor Biopharma
VOR
$253M
| $7.16M | 0.06% |
3,182,889
| – | – |
|
65
Abbott
ABT
$230B
| $7.16M | 0.06% |
+65,056
| New | +$7.16M |
|
66
Ferguson
FERG
$46.1B
| $7.14M | 0.06% |
36,995
| – | – |
|
67
Philip Morris
PM
$254B
| $7.13M | 0.06% |
+75,818
| New | +$7.13M |
|
68
RTX Corp
RTX
$212B
| $7.03M | 0.06% |
+83,608
| New | +$7.03M |
|
69
AT&T
T
$208B
| $6.59M | 0.06% |
+392,936
| New | +$6.59M |
|
70
IBM
IBM
$227B
| $5.75M | 0.05% |
+35,127
| New | +$5.75M |
|
71
Pyxis Oncology
PYXS
$91.2M
| $5.71M | 0.05% |
3,170,803
| – | – |
|
|
AUTL
72
Autolus Therapeutics
AUTL
$383M
| $5.7M | 0.05% |
885,471
-590,635
| -40% | -$3.8M |
|
73
Solid Biosciences
SLDB
$448M
| $5.7M | 0.05% |
928,169
| – | – |
|
74
Celldex Therapeutics
CLDX
$1.57B
| $5.49M | 0.05% |
+138,531
| New | +$5.49M |
|
|
75
Apple
AAPL
$3.54T
| $5.49M | 0.05% |
28,519
-2,272,360
| -99% | -$437M |
|